Literature DB >> 14500997

Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease.

Shlomo Rotshenker1.   

Abstract

Microglia and macrophages play critical roles in the response of the central and peripheral nervous systems (CNS and PNS, respectively) to injury and disease, one of which is the removal of degenerated myelin by phagocytosis. Myelin removal is efficient during Wallerian degeneration, which follows injury to PNS axons, and in CNS autoimmune demyelinating diseases (e.g., multiple sclerosis) but is inefficient after injury to CNS axons. We suggest that inefficient myelin removal results from deficient microglia activation, reflected by the failure to up-regulate Galectin-3/MAC-2 expression, which marks a state of activation correlated with efficient myelin phagocytosis. Surprisingly, whether or not executing myelin phagocytosis, CNS microglia express the alphaM/beta2 integrin complement receptor-3 (CR3/MAC-1), which has the potential of mediating efficient myelin phagocytosis. We hypothesize that CR3/MAC-1 might be present in distinct inactive and active states that determine, respectively, efficient and inefficient CR3/MAC-1-mediated myelin phagocytosis. We present evidence that CR3/MAC-1-mediated myelin phagocytosis is regulated in microglia and macrophages. First, CR3/MAC-1- mediated myelin phagocytosis has complement-dependent and -independent components. Second, an active complement system augments CR3/MAC-1-mediated myelin phagocytosis. Third, anti-alphaM monoclonal antibodies (MAbs) inhibit and anti-beta2 MAbs augment CR3/MAC-1-mediated myelin phagocytosis in the presence and absence of an active complement system. Fourth, an active complement system modulates MAb-induced regulation of CR3/MAC-1-mediated myelin phagocytosis. Overall, MAb-induced phagocytosis regulation might range three- to sevenfold from inefficient to efficient. We suggest that one of the mechanisms underlying MAb-induced phagocytosis regulation is the induction/stabilization of inactive and active conformational changes. Monoclonal antibody-induced phagocytosis regulation must reveal a mechanism by which native extracellular molecules bind to and regulate CR3/MAC-1-mediated myelin phagocytosis in microglia and macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500997     DOI: 10.1385/JMN:21:1:65

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  40 in total

Review 1.  Integrin affinity modulation.

Authors:  P E Hughes; M Pfaff
Journal:  Trends Cell Biol       Date:  1998-09       Impact factor: 20.808

2.  Deficient activation of microglia during optic nerve degeneration.

Authors:  F Reichert; S Rotshenker
Journal:  J Neuroimmunol       Date:  1996-11       Impact factor: 3.478

Review 3.  Central neuron-glial and glial-glial interactions following axon injury.

Authors:  H Aldskogius; E N Kozlova
Journal:  Prog Neurobiol       Date:  1998-05       Impact factor: 11.685

Review 4.  The role of microglia and macrophages in the pathophysiology of the CNS.

Authors:  G Stoll; S Jander
Journal:  Prog Neurobiol       Date:  1999-06       Impact factor: 11.685

5.  The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta.

Authors:  Shlomit Shamash; Fanny Reichert; Shlomo Rotshenker
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

6.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events.

Authors:  M K Robinson; D Andrew; H Rosen; D Brown; S Ortlepp; P Stephens; E C Butcher
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

8.  The cytokine network of wallerian degeneration: IL-10 and GM-CSF.

Authors:  H Be'eri; F Reichert; A Saada; S Rotshenker
Journal:  Eur J Neurosci       Date:  1998-08       Impact factor: 3.386

9.  A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration.

Authors:  G Mukhopadhyay; P Doherty; F S Walsh; P R Crocker; M T Filbin
Journal:  Neuron       Date:  1994-09       Impact factor: 17.173

10.  Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.

Authors:  H Rosen; S Gordon
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  51 in total

1.  Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury.

Authors:  Mauricio E Vargas; Junryo Watanabe; Simar J Singh; William H Robinson; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

2.  Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.

Authors:  Hua Zhang; Jeffrey L Bennett; A S Verkman
Journal:  Ann Neurol       Date:  2011-11-08       Impact factor: 10.422

Review 3.  Repair and regeneration of functional synaptic connections: cellular and molecular interactions in the leech.

Authors:  Yuanli Duan; Joseph Panoff; Brian D Burrell; Christie L Sahley; Kenneth J Muller
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

Review 4.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 5.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

6.  Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris.

Authors:  Xi Wang; Kai Cao; Xin Sun; Yongxiong Chen; Zhaoxia Duan; Li Sun; Lei Guo; Paul Bai; Dongming Sun; Jianqing Fan; Xijing He; Wise Young; Yi Ren
Journal:  Glia       Date:  2014-11-28       Impact factor: 7.452

Review 7.  Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.

Authors:  Timothy J Kopper; John C Gensel
Journal:  J Neurosci Res       Date:  2017-07-11       Impact factor: 4.164

8.  Deletion of Nrf2 impairs functional recovery, reduces clearance of myelin debris and decreases axonal remyelination after peripheral nerve injury.

Authors:  Linxia Zhang; Delinda Johnson; Jeffrey A Johnson
Journal:  Neurobiol Dis       Date:  2013-01-14       Impact factor: 5.996

9.  An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.

Authors:  Marieta M Ruseva; Valeria Ramaglia; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

10.  Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system.

Authors:  Xin Sun; Xi Wang; Tianxiang Chen; Tianyi Li; Kai Cao; Andrew Lu; Yongxiong Chen; Dongming Sun; Jianhong Luo; Jianqing Fan; Wise Young; Yi Ren
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.